FGSC #7151

Mutant Type

Genus: N

reporting_genes: dgr-1 al-3 his-6

species: Neurospora crassa

allele: KHY15 RP100 Y152M105

stock: 5375

glasgow:

mutagen:

Depositor: DDP

Link Group: VL R R

MT: a

Species No: 10

gene_back:

oppmt: 7150

trans:

ref1:

ref2:

site:

country:

ksudc_link: https://digital.lib.k-state.edu/item/neurospora-crassa/fgsc-7151

ksudc_link_html: https://digital.lib.k-state.edu/item/neurospora-crassa/fgsc-7151 ↗

Genes

Locus	Cultural Requirements	Link Group	Type
al-3	VR. Between his-1 and inl (1%) (1119, PB). Carotenoids deficient (398). Reported to lack geranylgeranyl pyrophosphate synthetase activity and is blocked in soluble fraction, consistent with lesion between isopentenyl pyrophosphate and geranylgeranyl pyrophosphate (445), but can still produce farnesyl pyrophosphate (445) and steroids (398). (See Fig. 9.) This evidence contradicts in vivo labeling results that indicate a lesion between prephytoene pyrophosphate and phytoene (572). Strains carrying allele Y234M470 (al-3ros), formerly called rosy (49), become partially pigmented but are readily distinguished from the wild type. ylo-1 can be scored in combination with al-3ros (Y234M470) (PB). Strains carrying other alleles (e.g., RP100) (1119) are white with a trace of pink pigment. Biosynthetic pathway for carotenoids. It is thought that the same prenyl transferase catalyzes all the steps from dimethylallyl pyrophosphate to geranylgeranyl pyrophosphate (444; R.W. Harding, personal communication), and it has been proposed that a separate prenyl transferase converts dimethylallyl pyrophosphate to farnesyl pyrophosphate for sterol synthesis (445). The conversion of phytoene to the various carotenoid pigments involves a series of dehydrogenations, cyclizations, and other reactions. There must also be a cis/trans isomerization analogous to that found in tomato (842). The sequence of some of these steps is still uncertain; the pathway must branch, and there may be alternate routes to some of the products. See references 228, 443, 444, 842 and citations therein for proposed sequences. al-1 is probably blocked in phytoene dehydrogenase (398). It is not known whether this enzyme catalyzes the whole series of dehydrogenations. al-2 is reported blocked between geranylgeranyl pyrophosphate and phytoene (445) and between prephytoene pyrophosphate and phytoene (572). al-3 is alternately reported blocked between isopentenyl pyrophosphate and geranylgeranyl pyrophosphate (445) and between prephytoene pyrophosphate and phytoene (572), but it is not blocked in the production of farnesyl pyrophosphate or sterols (398, 445). ylo-1 is evidently blocked in a late step, probably either in the conversion of lycopene to 3,4-dehydrolycopene or in the conversion of either torulene or gamma-carotene to neurosporaxanthin (see citations in reference 398).	VR	B
dgr-1	VL. Between rDNA, T(UK2-33), In(UK2-y)^L and T(AR30), caf-1 (7%). Resistant to 1 mM deoxyglucose, also resistant to sorbose at 5 mM. Grows more slowly that wild type on standard medium but growth is initially faster than that of wild type on media with mono- or disaccharides plus deoxyglucose. Conidiation is precocious.	VL	B
his-6	VR. Right of un-9 (6%) and pyr-6 (6 to 18%). No recombination with terminal translocation T(NMI49) (793, 808, 816, 818, PB). Report of IV linkage (646) not confirmed.Requires histidine. Blocked before imidazole glycerol phosphate (162, 1123) (Fig. 14). No intralocus complementation (95 alleles) (162). Intralocus recombination (172).	VR	B